EUVIMEDEUVIMED entdecken
Crossref

1α,25(OH)2D3 Regulates the TGF-β1/Samd Signaling Pathway Inhibition of Hepatic Stellate Cell Activation

Yihan Zhao, Jianghao Fan, Jia Wang, Jie Wan, Haiyan Ma, Xiaoying Sha, Hongli Wang

Drug Research · 01.04.2025 · 75 (03/04) · 94-99

DOI: 10.1055/a-2463-5530 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Research, erschienen am 01.04.2025. Verfasst von Yihan Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Xi'an Eighth Hospital, Xi'an, China. Hauptthemen laut MEDLINE: Hepatic Stellate Cells, Transforming Growth Factor beta1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To investigate the effect of 1α,25(OH)2D3 on hepatic stellate cells and the mechanism of the TGF-β1/Smad signaling pathway. LX2 cells were treated with TGF-β1 and different concentrations of 1α,25(OH)2D3. Cell proliferation was assessed using the CCK8 assay to determine the optimal concentration of 1α,25(OH)2D3 activity. The cell cycle and apoptotic rates were evaluated using flow cytometry. The expressions of Samd2, Samd3, Samd4, and Samd7 was assessed by western blotting, whereas the expression of MMP1, MMP13, and TIMP-1 was detected by qPCR. Compared with the control group, the 1α,25(OH)2D3 group had a higher apoptotic rate of LX2 cells, the cell cycle was blocked from the G1 stage to the S stage, the expressions of Samd2, Samd7, MMP1, and MMP13 increased, while the expressions of Samd3, Samd4, and TIMP-1 decreased. 1α,25(OH)2D3 inhibits hepatic stellate cell activation and exerts anti-hepatic fibrosis effects by downregulating the expression of Samd3, Samd4, TIMP-1 and upregulating the expression of Samd2, Samd4, MMP1, and MMP13.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatic Stellate CellsTransforming Growth Factor beta1Signal TransductionHumansCell ProliferationLiver CirrhosisTissue Inhibitor of Metalloproteinase-1Cell LineApoptosisMatrix Metalloproteinase 13Cell CycleMatrix Metalloproteinase 1

Substanzen

Transforming Growth Factor beta1Tissue Inhibitor of Metalloproteinase-1Matrix Metalloproteinase 13TIMP1 protein, humanMatrix Metalloproteinase 1TGFB1 protein, human

Autor:innen und Institutionen

  • Xi'an Eighth Hospital, Xi'an, China.
  • Second Clinical College, Shaanxi University of Traditional Chinese Medicine, Xianyang, China.

Zitieren

APA

Zhao, Y., Fan, J., Wang, J., Wan, J., Ma, H., Sha, X., & Wang, H. (2025). 1α,25(OH)2D3 Regulates the TGF-β1/Samd Signaling Pathway Inhibition of Hepatic Stellate Cell Activation. Drug Research, 75(03/04), 94-99. https://doi.org/10.1055/a-2463-5530

Vancouver

Zhao Y, Fan J, Wang J, Wan J, Ma H, Sha X, et al. 1α,25(OH)2D3 Regulates the TGF-β1/Samd Signaling Pathway Inhibition of Hepatic Stellate Cell Activation. Drug Research. 2025;75(03/04):94-99. doi:10.1055/a-2463-5530

BibTeX
@article{Zhao2025,
  author = {Zhao, Yihan and Fan, Jianghao and Wang, Jia and Wan, Jie and Ma, Haiyan and Sha, Xiaoying and Wang, Hongli},
  title = {1α,25(OH)2D3 Regulates the TGF-β1/Samd Signaling Pathway Inhibition of Hepatic Stellate Cell Activation},
  journal = {Drug Research},
  year = {2025},
  volume = {75},
  number = {03/04},
  pages = {94--99},
  doi = {10.1055/a-2463-5530}
}
Kostenlos starten →